Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 117,290 | 130,414 | 108,890 | 109,816 | 81,778 |
| Cost of Goods | 41,588 | 42,646 | 29,821 | 33,503 | 22,222 |
| Gross Profit | 75,702 | 87,768 | 79,069 | 76,313 | 59,556 |
| Operating Expenses | 97,740 | 91,564 | 80,937 | 82,556 | 37,780 |
| Operating Income | -21,450 | -3,150 | -1,047 | -5,740 | 21,998 |
| Interest Expense | -1,550 | -1,916 | 1,347 | 1,681 | 0 |
| Other Income | 363 | -1,516 | -757 | -1,645 | 2,457 |
| Pre-tax Income | -19,537 | -2,750 | -3,151 | -9,066 | 24,455 |
| Income Tax | -5,132 | -2,725 | -882 | 1,714 | -73 |
| Net Income Continuous | -14,405 | -25 | -2,269 | -10,780 | 24,528 |
| Net Income Discontinuous | -401 | N/A | N/A | N/A | N/A |
| Minority Interests | -3,529 | -1,529 | -1,198 | -6,654 | -408 |
| Net Income | $-11,277 | $-364 | $-1,071 | $-4,126 | $24,936 |
| EPS Basic Total Ops | -0.19 | 0.00 | -0.03 | -0.10 | -0.02 |
| EPS Basic Continuous Ops | -0.18 | -0.38 | -0.05 | -0.26 | 0.59 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.19 | 0.00 | -0.03 | -0.10 | -0.02 |
| EPS Diluted Continuous Ops | -0.18 | -0.38 | -0.05 | -0.26 | 0.59 |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,971 | $8,540 | $7,475 | $1,739 | $29,182 |